Dna X (SONM) Operating Expenses (2018 - 2026)

Dna X's Operating Expenses history runs 9 years deep, the most recent figure standing at $3.6 million for Q1 2026.

• Quarterly Operating Expenses rose 315.86% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 181.0% YoY) and the FY2025 annual result came in at $5.4 million, up 74.39% from the prior year.
• Operating Expenses was $3.6 million for Q1 2026 at Dna X, up from -$15.7 million in the prior quarter.
• Across five years, Operating Expenses topped out at $9.4 million in Q2 2024 and bottomed at -$18.5 million in Q4 2024.
• A 5-year average of $2.9 million and a median of $5.2 million in 2022 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2024 — Operating Expenses plunged 390.79% — and 2026, when it soared 315.86%.
• Dna X's Operating Expenses stood at $5.0 million in 2022, then grew by 27.73% to $6.4 million in 2023, then plunged by 390.79% to -$18.5 million in 2024, then increased by 15.43% to -$15.7 million in 2025, then surged by 123.08% to $3.6 million in 2026.
• Business Quant data shows SONM's Operating Expenses at $3.6 million in Q1 2026, -$15.7 million in Q4 2025, and $5.8 million in Q3 2025.